Practical perspectives on how to communicate MDS subclassifications with affected patients and caregivers. Bruce Feinberg, DO: Tracey, at the patient level, when you’re dealing with the health ...

Expert perspectives on the changes in MDS subclassifications as understandings of the disease have evolved. Bruce Feinberg, DO: Amer, we’ve heard about it, and it’s clear that everyone involved—from ...

—In a recent study, investigators in Spain sought to discover which gene mutations were responsible for the transformation of myelodysplastic syndrome (MDS) to secondary acute myeloid leukemia (sAML).

Incorporating Novel Targeted and Immunotherapeutic Agents in the Treatment of B-Cell Lymphomas Myelodysplastic syndrome (MDS) classification currently relies mainly on its morphologic features and ...

The prognostic impact of monocytosis in patients with myelodysplastic syndromes (MDS) is not well-studied and not been clearly defined. Patients with MDS and monocytosis had a shorter overall survival ...

Physician scientists at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have published a review in the Journal of the American Medical Association that ...